Ocugen Inc (OCGN) Company Profile & Statistics

Ocugen Inc
OCGN
(Nasdaq - US)
Open
0.92
+0.02 (+2.12%)
in:usd•As of: Nov 22, 2024 12:18 UTC -5
Open
0.91
High
0.93
Low
0.89

About Ocugen Inc

CEO

Shankar Musunuri

Headquarters

11 great valley parkway

malvern, pa 19355, united states

Auditor

Ernst & Young LLP

Employees

Share Holders

Website

http://ocugen.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly known as Histogenics Cp, is based in Malvern, Pennsylvania.

Ocugen Inc Statistics

Valuation Measures

Market Capitalization ²	268.01M
Enterprise Value	232.21M
Enterprise Value/EBITDA (ttm)	-4.56
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	6.19
Price to Sales (ttm)	27.29
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	-532.51%
Profit Margin (ttm)	-1108.85%
Return on Equity (ttm)	-154.75%
Return on Invested Capital (ttm)	-176.22%
Return on Assets (ttm)	-90.79%

Income Statement

Revenue (ttm)	4.70M
Revenue Per Share (ttm)	0.02
Gross Profit (ttm)	4.70M
EBITDA (ttm)³	-50.89M
Net Income Avi to Common (ttm)	-51.14M
Diluted EPS (ttm)	-0.18

Share Statistics

Beta (5Y Monthly)	3.75
52-Week Change	124.44%
S&P500 52-Week Change	30.87%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	291.32M
Dividend Yield	0.00%
Float ⁴	278.82M
% Held by Insiders	4.29%
% Held by Institutions	10.27%

Balance Sheet

Total Cash (mrq)	38.70M
Total Cash Per Share (mrq)	0.13
Total Debt (mrq)	2.89M
Total Debt/Equity (mrq)	7.11%
Current Ratio (mrq)	2.58%
Quick Ratio (mrq)	2.58%
Book Value Per Share (mrq)	0.14

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.11
Free Cash Flow (ytd)	-35.15M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Ocugen Inc

Trade With A Regulated Broker